METYS PHARMACEUTICALS

metys-pharmaceuticals-logo

Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect of several important cancer treatments. MP-101 is an orally-active modulator of glutamate signalling in spine and brain. Glutamate signalling has long been a sought-after target for the development of new central nervous system drug candidates. MP-101 is a particularly well-suited candidate, with outstanding pharmaceutic properties; it is a smal... l molecule, obtained by a straight-forward chemical manufacturing process. It is also orally active in a wide range of rodent models of central nervous system disorders, such as depression, cognition, or neuropathic pain. MP-101 is a patent-pending non-racemic mixture of the left-handed and right-handed versions (the "enantiomers") of dimiracetam. It is not a one-to-one mixture (a "racemate"), but a ratio that has been chosen because it is - unexpectedly - considerably more potent pharmacologically than the racemate. While the one-to-one mixture has long been known to be superior to either of the two single-handed enantiomers alone, Metys Pharmaceuticals has discovered that certain mixtures of dimiracetam enantiomers are far more potent still. Metys Pharmaceuticals has licensed the world-wide exclusive rights to racemic dimiracetam from Neurotune AG, including the entire dossier of regulatory studies supporting clinical trials of racemic dimiracetam. Metys Pharmaceuticals now aims to use these pharmacological, toxicological and clinical data obtained with racemic dimiracetam to support the future clinical trials of MP-101.

#SimilarOrganizations #People #Financial #Website #More

METYS PHARMACEUTICALS

Industry:
Medical Medical Device Pharmaceutical

Founded:
2013-04-23

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.metys-pharma.ch

Total Employee:
1+

Status:
Active

Contact:
+41794087972

Email Addresses:
[email protected]

Total Funding:
1.51 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Mobile Non Scaleable Content Nginx Google Apps For Business


Similar Organizations

brachydose-logo

BrachyDOSE

BrachyDOSE is a cancer treatment quality control tool to help oncologists to reach best possible treatment results.

kamedi-gmbh-logo

Kamedi GmbH

Kamedi is providing innovative medical devices for a great outdoor experience

mater-dyamics-logo

Mater Dyamics

Mater Dynamics develops smart food packging for product traceability and quality control.

ponce-de-leon-pharmaceuticals-logo

Ponce De Leon Pharmaceuticals

Developer of a health formulation comprised of GRAS (Generally Regarded As Safe) components.

portal-instruments-logo

Portal Instruments

Portal Instruments is an early stage company that offers medical device.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

wolfgang-söhngen_image

Wolfgang Söhngen Member of the Board of Directors @ Metys Pharmaceuticals
Board_member
2020-01-01

Current Employees Featured

not_available_image

Carlo Farina
Carlo Farina consulting Head of Chemistry @ Metys Pharmaceuticals
consulting Head of Chemistry
2013-04-23

michael-scherz_image

Michael Scherz
Michael Scherz Founder & CEO @ Metys Pharmaceuticals
Founder & CEO
2013-04-23

not_available_image

Elisabet Lindberg
Elisabet Lindberg consulting Chief Medical Officer @ Metys Pharmaceuticals
consulting Chief Medical Officer
2014-09-15

not_available_image

Roberto Maj
Roberto Maj consulting Head of Preclinical Development @ Metys Pharmaceuticals
consulting Head of Preclinical Development
2014-09-15

not_available_image

Patrick Scherrer
Patrick Scherrer Lead Financial Advisor @ Metys Pharmaceuticals
Lead Financial Advisor
2013-04-23

not_available_image

Maria Lindström
Maria Lindström consulting Head of Clinical Operations @ Metys Pharmaceuticals
consulting Head of Clinical Operations
2014-09-15

Founder


michael-scherz_image

Michael Scherz

Investors List

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Metys Pharmaceuticals

Official Site Inspections

http://www.metys-pharma.ch

  • Host name: antiqua.sui-inter.net
  • IP address: 80.74.148.70
  • Location: Neunkirch Switzerland
  • Latitude: 47.6901
  • Longitude: 8.4998
  • Timezone: Europe/Zurich
  • Postal: 8213

Loading ...

More informations about "Metys Pharmaceuticals"

metys-pharma.ch | About

Contact. Novaremed AG Elisabethenstrasse 18 4051 Basel, Switzerland. Phone: +41 61 5640297 E-mail: [email protected]See details»

Metys Pharmaceuticals - Crunchbase Company Profile …

Contact Email [email protected] Phone Number +41794087972 Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy …See details»

Metys Pharmaceuticals AG Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Metys Pharmaceuticals AG of Basel, BASEL-STADT. Get the latest business insights from Dun & …See details»

Metys Pharmaceuticals AG :: Switzerland - OpenCorporates

Free and open company data on Switzerland company Metys Pharmaceuticals AG (company number 1137897), Elisabethenstrasse, 18, Basel, 4051See details»

Metys Pharmaceuticals AG - Basel, Schweiz - bionity.com

Metys Pharmaceuticals wurde 2013 von Dr. Michael Scherz, einem Medizinchemiker mit einer 25-jährigen Karriere in der Arzneimittelentwicklung und -entdeckung, gegründet. ... metys …See details»

Metys Pharmaceuticals - Company Profile - Tracxn

Feb 24, 2025 Metys Pharmaceuticals - Developer of drugs for chemotherapy-induced peripheral neuropathy. Acquired by Novaremed. Raised funding over 2 rounds from 2 investors. Founded …See details»

metys-pharma.ch | Impressum

Metys Pharmaceuticals AG, a wholly-owned subsidiary of Novaremed AG Elisabethenstrasse 18 4051 Basel. Webdesign & Programmierung JKweb, Webdesign Basel. Metys Pharmaceuticals …See details»

Metys Pharmaceuticals AG, Basel | business-monitor.ch

Metys Pharmaceuticals AG, aktiv in "Forschung und Entwicklung im Bereich Biotechnologie" - Handelsregistereintrag, Netzwerk, Branche, Entscheidungsträger und Kontakte, SHAB. ...See details»

Metys Pharmaceuticals Ag · Gerbergasse 30, Basel, BS 4001, CHE

Metys Pharmaceuticals Ag (SAM# GM4XS34LUTW1) is an entity registered with U.S. General Services Administration (GSA), System for Award Management (SAM). The registration date …See details»

Metys Pharmaceuticals AG:Company Profile & Technical Research ...

Metys Pharmaceuticals AG is a company that provides Chemotherapy-induced peripheral neuropathy, Dimiracetam, Medical equipment and more. Metys Pharmaceuticals AG is …See details»

Metys Pharmaceuticals AG - Drug pipelines, Patents, Clinical trials ...

Explore Metys Pharmaceuticals AG with its drug pipeline, therapeutic area, technology platform, 1 news, and 3 literature, Disease Domain:Nervous System Diseases, Technology …See details»

Metys Pharmaceuticals - Overview, News & Similar companies

View Metys Pharmaceuticals (www.metys-pharma.ch) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees …See details»

Metys Pharmaceuticals AG - Handelszeitung

Die Gesellschaft die Erforschung, die Entwicklung, die Herstellung und den Vertrieb von pharmazeutischen, biologischen, diagnostischen und anderen Produkten auf dem Gebiet der …See details»

Metys Pharmaceuticals AG - startup.ch

Metys Pharmaceuticals AG: Michael Scherz founded Metys Pharmaceuticals in April 2013 to re-start the clinical development of dimiracetam. The company is developing dimiracetam for …See details»

Metys Pharmaceuticals - VentureRadar

Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect of several important cancer …See details»

Metys Pharmaceuticals AG - Basel, Switzerland - bionity.com

Metys-pharma.ch. Contact. Profile ... Metys Pharmaceuticals is developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy. In the US alone, in a …See details»

Metys Pharmaceuticals - Craft

Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments. It develops MP-101, an …See details»

List of Pharmaceutical Companies in Switzerland - Page 3 of 4 ...

Website: www.merz.ch. Metys Pharmaceuticals AG. Address: Gerbergasse 30, 4001 Basel, Switzerland Fax: +41 61 568 40 70 Website: metys-pharma.ch. MSD International GmbH. …See details»

metys-pharma.ch | SMi Pain Therapeutics

Metys-pharma.ch. About. Contact; SMi Pain Therapeutics overview. London, UK, 14 May 2019. The SMi Pain Therapeutics Congress of 14-15 May 2019 is taking place under the co …See details»

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma …

1 day ago How we use your personal data How we use your information depends on the product and service that you use and your relationship with us.See details»

linkstock.net © 2022. All rights reserved